BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 7927324)

  • 1. Molecular analysis of aniridia patients for deletions involving the Wilms' tumor gene.
    Drechsler M; Meijers-Heijboer EJ; Schneider S; Schurich B; Grond-Ginsbach C; Tariverdian G; Kantner G; Blankenagel A; Kaps D; Schroeder-Kurth T
    Hum Genet; 1994 Oct; 94(4):331-8. PubMed ID: 7927324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct pulsed field gel electrophoresis of Wilms' tumors shows that DNA deletions in 11p13 are rare.
    Royer-Pokora B; Ragg S; Heckl-Ostreicher B; Held M; Loos U; Call K; Glaser T; Housman D; Saunders G; Zabel B
    Genes Chromosomes Cancer; 1991 Mar; 3(2):89-100. PubMed ID: 1648959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raised risk of Wilms tumour in patients with aniridia and submicroscopic WT1 deletion.
    van Heyningen V; Hoovers JM; de Kraker J; Crolla JA
    J Med Genet; 2007 Dec; 44(12):787-90. PubMed ID: 17630404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of chromosome 11p imbalances in aniridia and Wilms tumor patients.
    Busch M; Leube B; Thiel A; Schanze I; Beier M; Royer-Pokora B
    Am J Med Genet A; 2013 May; 161A(5):958-64. PubMed ID: 23494989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymerase chain reaction-based risk assessment for Wilms tumor in sporadic aniridia.
    Gupta SK; De Becker I; Guernsey DL; Neumann PE
    Am J Ophthalmol; 1998 May; 125(5):687-92. PubMed ID: 9625553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hereditary renal tumors: Wilms' tumor--congenital anomalies' syndrome].
    Tsuchida Y; Yokomori K; Choi SH
    Nihon Rinsho; 1995 Nov; 53(11):2742-8. PubMed ID: 8538037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Submicroscopic deletions at the WAGR locus, revealed by nonradioactive in situ hybridization.
    Fantes JA; Bickmore WA; Fletcher JM; Ballesta F; Hanson IM; van Heyningen V
    Am J Hum Genet; 1992 Dec; 51(6):1286-94. PubMed ID: 1334370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent chromosome aberrations revealed by molecular cytogenetic studies in patients with aniridia.
    Crolla JA; van Heyningen V
    Am J Hum Genet; 2002 Nov; 71(5):1138-49. PubMed ID: 12386836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The distal region of 11p13 and associated genetic diseases.
    Mannens M; Hoovers JM; Bleeker-Wagemakers EM; Redeker E; Bliek J; Overbeeke-Melkert M; Saunders G; Williams B; van Heyningen V; Junien C
    Genomics; 1991 Oct; 11(2):284-93. PubMed ID: 1769647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms' tumor gene.
    Rose EA; Glaser T; Jones C; Smith CL; Lewis WH; Call KM; Minden M; Champagne E; Bonetta L; Yeger H
    Cell; 1990 Feb; 60(3):495-508. PubMed ID: 2154334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetics and molecular genetics of Wilms' tumor of childhood.
    Slater RM; Mannens MM
    Cancer Genet Cytogenet; 1992 Jul; 61(2):111-21. PubMed ID: 1322233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long range physical map of the Wilms' tumor-aniridia region on human chromosome 11.
    Compton DA; Weil MM; Jones C; Riccardi VM; Strong LC; Saunders GF
    Cell; 1988 Dec; 55(5):827-36. PubMed ID: 2847871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous inactivation of WT1 in a Wilms' tumor associated with the WAGR syndrome.
    Gessler M; König A; Moore J; Qualman S; Arden K; Cavenee W; Bruns G
    Genes Chromosomes Cancer; 1993 Jul; 7(3):131-6. PubMed ID: 7687865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two anonymous DNA segments distinguish the Wilms' tumor and aniridia loci.
    Davis LM; Stallard R; Thomas GH; Couillin P; Junien C; Nowak NJ; Shows TB
    Science; 1988 Aug; 241(4867):840-2. PubMed ID: 2841760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The beta-subunit of follicle-stimulating hormone is deleted in patients with aniridia and Wilms' tumour, allowing a further definition of the WAGR locus.
    Glaser T; Lewis WH; Bruns GA; Watkins PC; Rogler CE; Shows TB; Powers VE; Willard HF; Goguen JM; Simola KO
    Nature; 1986 Jun 26-Jul 2; 321(6073):882-7. PubMed ID: 3014343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mouse model of the aniridia-Wilms tumor deletion syndrome.
    Glaser T; Lane J; Housman D
    Science; 1990 Nov; 250(4982):823-7. PubMed ID: 2173141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A FISH approach to defining the extent and possible clinical significance of deletions at the WAGR locus.
    Crolla JA; Cawdery JE; Oley CA; Young ID; Gray J; Fantes J; van Heyningen V
    J Med Genet; 1997 Mar; 34(3):207-12. PubMed ID: 9132491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour.
    Pelletier J; Bruening W; Li FP; Haber DA; Glaser T; Housman DE
    Nature; 1991 Oct; 353(6343):431-4. PubMed ID: 1654525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nude mouse Wilms' tumor line (KCMC-WT-1) derived from an aniridia patient with monoalleleic partial deletion of chromosome 11p.
    Nagashima Y; Nishihira H; Miyagi Y; Tanaka Y; Sasaki Y; Nishi T; Imaizumi K; Aoki I; Misugi K
    Cancer; 1996 Feb; 77(4):799-804. PubMed ID: 8616775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aniridia, Wilms' tumor and human chromosome 11.
    Bickmore WA; Hastie ND
    Ophthalmic Paediatr Genet; 1989 Dec; 10(4):229-48. PubMed ID: 2560823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.